<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9">
  <url><loc>https://peptide.global/story/eris-sundae-semaglutide-leads-india</loc><news:news><news:publication><news:name>Peptide Global</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-31T05:20:00.000Z</news:publication_date><news:title>Eris Sundae semaglutide tops Indian prescriptions but ranks second by value</news:title></news:news></url>
  <url><loc>https://peptide.global/story/wegovy-epar-update-liver-data-sites</loc><news:news><news:publication><news:name>Peptide Global</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-30T06:16:00.000Z</news:publication_date><news:title>Wegovy EPAR update in the EU logs liver data and new plant sites</news:title></news:news></url>
  <url><loc>https://peptide.global/story/laurus-labs-q2-peptide-resin-stake</loc><news:news><news:publication><news:name>Peptide Global</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-10-30T05:32:00.000Z</news:publication_date><news:title>Laurus Labs Q2 results double profit as it buys into a peptide resin maker</news:title></news:news></url>
</urlset>